Misplaced Pages

ACE inhibitor and thiazide combination

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Buidhe (talk | contribs) at 02:18, 5 November 2023 (Moving from Category:Combination drugs to Category:Combination antihypertensive drugs using Cat-a-lot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 02:18, 5 November 2023 by Buidhe (talk | contribs) (Moving from Category:Combination drugs to Category:Combination antihypertensive drugs using Cat-a-lot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) A combination of antihypertensive drugs used to treat hypertension

An ACE inhibitor and thiazide combination is a drug combination used to treat hypertension (high blood pressure). They are given by mouth. ACE inhibitors reduce the activity of angiotensin-converting enzyme (ACE) which produces angiotensin II, a hormone that constricts blood vessels. Thiazides are a class of diuretics that inhibit the thiazide receptor, thereby increasing urine production and reducing excess water and salt in the body. Several organizations recommend combination therapy for hypertension in cases of failure of a single drug to achieve target blood pressure, or even as a first line treatment for some patients.

Examples

Pharmaceutical compound
Quinapril/hydrochlorothiazide
Combination of
QuinaprilAngiotensin converting enzyme inhibitor
HydrochlorothiazideThiazide diuretic
Clinical data
Trade namesAccuretic
AHFS/Drugs.comMultum Consumer Information
ATC code
Legal status
Legal status
Identifiers
ChemSpider
KEGG
Pharmaceutical compound
Lisinopril/hydrochlorothiazide
Combination of
LisinoprilACE inhibitor
HydrochlorothiazideThiazide diuretic
Clinical data
MedlinePlusa601070
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
KEGG
  (verify)

Fosinopril/hydrochlorothiazide

Pharmaceutical compound
Fosinopril/hydrochlorothiazide
Combination of
FosinoprilAngiotensin converting enzyme inhibitor
HydrochlorothiazideThiazide diuretic
Clinical data
Trade namesMonopril HCT
Pregnancy
category
  • C (1st trimester); D (2nd & 3rd trimesters)
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)

Fosinopril/hydrochlorothiazide (trade name Monopril HCT) has a boxed warning about its risk to cause morbidity and mortality in the baby when being used during pregnancy (2nd and 3rd trimesters).

FDA modified its labeling on February, 2009 to include a precaution of drug interaction with gold. "Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including Monopril/Monopril HCT."

See also

References

  1. "Choice of drug therapy in primary (essential) hypertension".
  2. Accuretic Multum Consumer Information
  3. "Prinzide Uses, Side Effects & Warnings - Drugs.com". drugs.com.
  4. "Zestoretic: Uses, Dosage & Side Effects - Drugs.com". drugs.com.
  5. "fosinopril/hydrochlorothiazide (Rx) - Contraindications & Cautions". Medscape. Retrieved 13 December 2013.
  6. "Monopril HCT (fosinopril/hydrochlorothiazide) 20/12.5mg and 10/12.5mg Tablets February 2009". FDA.
Antihypertensive drugs acting on the renin–angiotensin system (C09)
ACE inhibitors
("-pril")
AIIRAs
("-sartan")
Renin inhibitors
("-kiren")
Dual ACE/NEP inhibitors
Neprilysin inhibitors
Other
Categories: